Trump ‘cognitive decline’ rumours spark White House fury – ‘fake and desperate!’ | World | News
The White House has launched a furious rebuttal to mounting claims about Donald Trump’s cognitive health, calling the claims “bogus and hopeless” and accusing critics of unethical behavior. A spokesman for Mr. Trump dismissed the latest comments, prompted in part by an editorial in The, in a sharply worded statement. BMJ— singled out medical experts who publicly speculated about the president’s condition as “false and defamatory.”
Expressing his concerns, the spokesperson said Dr. In an apparent reference to Kamran Abbasi and other clinicians, he told Express.co.uk: “These are false and defamatory claims made by a ‘doctor’ who is making unethical speculations about health issues of which he has no knowledge.”
The response marks a significant escalation in tone from the administration, which has so far largely ignored questions about Mr. Trump’s mental acuity. Instead, authorities are now directly challenging both the credibility and motivations of those fueling the debate.
The spokesperson insisted that Trump’s performance in office belies claims of decline, pointing to what they described as his “sharpness, unparalleled energy and historic accessibility.” They argued that the president’s demanding schedule and frequent public appearances showed a level of endurance inconsistent with his injury claims.
The White House has also sought to draw a sharp contrast with Mr. Trump’s predecessor, Joe Biden, in a move that reframed the debate as a partisan issue. The statement accused “legacy media” of “deliberately covering up” what it described as the “serious mental and physical decline” Mr Biden suffered during his time in office.
“Unlike the Biden White House, President Trump and his entire team have been completely open and transparent about the President’s health, which remains exceptional,” the spokesperson added.
The statements reflect a broader strategy by the administration to direct scrutiny towards its critics and suggest that the current wave of concern has a political motivation rather than a medical basis. Mr. Trump’s allies have increasingly echoed that line, arguing that speculation about his health is designed to undermine his authority at a time of rising global tensions.
However, with the intervention of the BMJ and Dr. He ensured that the issue remained on the public agenda with the comments of names such as David Nicholl and Trish Greenhalgh. While these experts refrained from making any diagnoses, they noted what they described as “warning signs” and called for more rigorous, formal evaluation.
The White House response specifically avoids such specific clinical discussions, focusing instead on the ethics of asking such questions in the first place. Authorities are invoking longstanding professional standards that bar remote identification of public figures, accusing critics of acting without proper evidence or access.
As the debate intensified, Dr. The broader issue raised by Kamran Abbasi—whether there should be mandatory, independent cognitive testing for leaders—shows little sign of abating. Instead, the administration’s strong pushback appears to have hardened attitudes on both sides, ensuring that the debate over the president’s fitness remains a contentious feature of the political landscape.
